BioLife Solutions Stock Analysis
Technical stock analysis for 18 January 2019
BioLife Solutions fell by -3.48% in the last day from $12.64 to $12.20 and has now fallen 3 days in a row. The price has been going up and down for this period, and there has been a 3.57% gain for the last 2 weeks. Volume has increased in the last day by 29 065 shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 162 209 shares bought and sold for approximately $1.98 million.
Close price at the end of the last trading day (Friday, 18th Jan 2019) of the BLFS stock was $12.20. This is 3.48% less than the trading day before Thursday, 17th Jan 2019.
During day the stock fluctuated 5.11% from a day low at $12.13 to a day high of $12.75.
30 day high of the BLFS stock price was $13.52 and low was $9.15.
90 day high was $14.70 and low was $9.15.
52 week high for the BioLife Solutions - $26.35 and low - $4.63.
BioLife Solutions lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -3.45% during the next 3 months and, with 90% probability hold a price between $9.03 and $13.11 at the end of this period.
There are mixed signals in the stock today. A sales signal was issued from a pivot top point on Wednesday January 16, 2019, which indicates further falls until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely. BioLife Solutions holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $12.56. On a fall, the stock will find some support from the long-term average at approximately $11.54. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal.
Relative Strength Index (RSI)
RSI14 is 50 and the stock is currently not being overbought or oversold
Support & Resistance
BioLife Solutions finds support from accumulated volume at $11.59.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.62 between high and low, or 5.11%. For the last week, the stock has had a daily average volatility of 5.09%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
BioLife Solutions holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Hold/Accumulate to a Sell Candidate.
|BLFS $12.20 $-0.44(-3.48%)|
BLFS is down $0.44 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for BLFS based on the 1-3 month system that more than doubles the S&P 500.
Click here – the BLFS analysis is free »